日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

siRNA conjugate with high albumin affinity and degradation resistance for delivery and treatment of arthritis in mice and guinea pigs

用于小鼠和豚鼠关节炎递送和治疗的具有高白蛋白亲和力和抗降解性的siRNA偶联物

Juan M Colazo ,Megan C Keech ,Veeraj Shah ,Ella N Hoogenboezem ,Justin H Lo ,Nora Francini ,Nina T Cassidy ,Fang Yu ,Alexander G Sorets ,Joshua T McCune ,Carlisle R DeJulius ,Hongsik Cho ,Danielle L Michell ,Tristan Maerz ,Kacey C Vickers ,Katherine N Gibson-Corley ,Karen A Hasty ,Leslie J Crofford ,Rebecca S Cook ,Craig L Duvall

Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy

通过对siRNA缀合物进行结构优化以增强其与白蛋白的结合能力,可实现有效的MCL1靶向癌症治疗。

Ella N Hoogenboezem ,Shrusti S Patel ,Justin H Lo ,Ashley B Cavnar ,Lauren M Babb ,Nora Francini ,Eva F Gbur ,Prarthana Patil ,Juan M Colazo ,Danielle L Michell ,Violeta M Sanchez ,Joshua T McCune ,Jinqi Ma ,Carlisle R DeJulius ,Linus H Lee ,Jonah C Rosch ,Ryan M Allen ,Larry D Stokes ,Jordan L Hill ,Kasey C Vickers ,Rebecca S Cook ,Craig L Duvall

Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer

Dusp4 和 p53 的缺失与 Dbf4 的扩增相结合,通过限制细胞周期和逃避复制应激来驱动乳腺癌中的肿瘤发生

Ann Hanna #, Mellissa J Nixon #, M Valeria Estrada, Violeta Sanchez, Quanhu Sheng, Susan R Opalenik, Abigail L Toren, Joshua Bauer, Phillip Owens, Frank M Mason, Rebecca S Cook, Melinda E Sanders, Carlos L Arteaga, Justin M Balko

Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer

肿瘤细胞中的选择性谷氨酰胺代谢抑制可提高三阴性乳腺癌中的抗肿瘤 T 淋巴细胞活性

Deanna N Edwards, Verra M Ngwa, Ariel L Raybuck, Shan Wang, Yoonha Hwang, Laura C Kim, Sung Hoon Cho, Yeeun Paik, Qingfei Wang, Siyuan Zhang, H Charles Manning, Jeffrey C Rathmell, Rebecca S Cook, Mark R Boothby, Jin Chen

Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch

治疗性 MK2 抑制剂可阻断病理性血管平滑肌细胞表型转换

J William Tierney, Brian C Evans, Joyce Cheung-Flynn, Bo Wang, Juan M Colazo, Monica E Polcz, Rebecca S Cook, Colleen M Brophy, Craig L Duvall

MLL3 is a de novo cause of endocrine therapy resistance

MLL3 是内分泌治疗耐药性的新生原因

Kimberly M Stauffer, David L Elion, Rebecca S Cook, Thomas Stricker

Weight change and risk of the foundation of National Institute of Health Sarcopenia-defined low lean mass: Data from the National Health and Nutrition examination surveys 1999-2004

体重变化与美国国立卫生研究院定义的肌少症基础疾病风险:来自1999-2004年全国健康与营养调查的数据

Batsis, John A; Petersen, Curtis L; Crow, Rebecca S; Cook, Summer B; Stevens, Courtney J; Seo, Lillian M; Brooks, Emma; Mackenzie, Todd A

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

MEK 活化调节糖酵解并支持 TNBC 中的抑制性髓系细胞

Derek A Franklin, Joe T Sharick, Paula I Ericsson-Gonzalez, Violeta Sanchez, Phillip T Dean, Susan R Opalenik, Stefano Cairo, Jean-Gabriel Judde, Michael T Lewis, Jenny C Chang, Melinda E Sanders, Rebecca S Cook, Melissa C Skala, Jennifer Bordeaux, Jehovana Orozco Bender, Christine Vaupel, Gary Geis

Microparticle Depots for Controlled and Sustained Release of Endosomolytic Nanoparticles

用于控制和持续释放胞内溶解纳米粒子的微粒储库

Kyle M Garland #, Sema Sevimli #, Kameron V Kilchrist, Craig L Duvall, Rebecca S Cook, John T Wilson

Therapeutic inhibition of Mcl-1 blocks cell survival in estrogen receptor-positive breast cancers

Mcl-1 的治疗性抑制可阻止雌激素受体阳性乳腺癌细胞存活

Michelle M Williams, David L Elion, Bushra Rahman, Donna J Hicks, Violeta Sanchez, Rebecca S Cook